June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Assessment of scotopic microperimetry as a functional marker in patients with inherited retinal disease.
Author Affiliations & Notes
  • Laura Jayne Taylor
    Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, Oxfordshire, United Kingdom
    Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom
  • Amandeep Singh Josan
    Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, Oxfordshire, United Kingdom
    Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom
  • Jasleen Kaur Jolly
    Anglia Ruskin University Vision and Eye Research Institute, Cambridge, United Kingdom
  • Robert E MacLaren
    Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, Oxfordshire, United Kingdom
    Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom
  • Footnotes
    Commercial Relationships   Laura Taylor None; Amandeep Josan None; Jasleen Jolly None; Robert MacLaren None
  • Footnotes
    Support  NIHR Oxford Biomedical Research Centre
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 4538 – F0325. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Laura Jayne Taylor, Amandeep Singh Josan, Jasleen Kaur Jolly, Robert E MacLaren; Assessment of scotopic microperimetry as a functional marker in patients with inherited retinal disease.. Invest. Ophthalmol. Vis. Sci. 2022;63(7):4538 – F0325.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Many inherited retinal degenerations (IRD) present with nyctalopia and peripheral vision loss. Despite this, spatial assessments of scotopic visual function are limited. Scotopic microperimetry combines scotopic two-colour (cyan and red stimuli) perimetry with fundus-controlled microperimetry. By analysing the cyan minus red stimuli sensitivity differences, it enables scotopic central retinal sensitivity mapping and spatial identification of photoreceptor dysfunction. Mesopic microperimetry has become a prominent outcome measure in IRD clinical trials. However, the use of scotopic microperimetry in IRDs is less well established, we sought to determine more about the usefulness of this test.

Methods : Participants underwent 20 minutes dark adaptation before two-colour scotopic microperimetry, on one eye, using the Macular Integrity Assessment System (MAIA; CenterVue, Padova, Italy), 37-point, ultra-wide radial grid, with cyan and red stimuli, respectively. Five participants underwent repeat scotopic testing. The reliability indices and repeatability were analysed.

Results : Thirteen participants with genetically confirmed IRD diagnoses (CHM = 10, USH2A =2 and RHO =1) and good visual acuity (mean VA 83 [SD±5] ETDRS letters) completed microperimetry. Three participants were excluded due to >20% fixation losses. The remaining 10 participants showed good fixation stability with a mean 95% bivariate contour ellipse fixation area of 1.57 (SD±1.71) and 2.56 (SD±3.62) degrees2 for cyan and red stimuli, respectively. Mean cyan sensitivity (dB) was 5.36 (SD±6.9), mean red sensitivity was 8.41 (SD±7.7), cyan minus red sensitivity was -3.19 (SD±4.9). The individual test point repeatability for cyan stimuli was ±6.42dB, ±4.67dB for red stimuli and ±7.57dB for cyan minus red. Cyan minus red sensitivity plots showed both choroideremia and USH2A-associated retinitis pigmentosa (RP) participants had mixed rod/cone photoreceptor dysfunction. Whereas the Rho-associated RP participant showed diffuse rod specific dysfunction.

Conclusions : Scotopic microperimetry appears a reliable and repeatable marker of scotopic central macular sensitivity. However, to more accurately model the patterns of photoreceptor dysfunction in different IRDs, it may be necessary to consider specific pointwise test-retest variability values when categorising between rod versus cone retinal dysfunction.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×